Angiogenese og molekylærbiologiske markører ved aggressiv prostatakreft
- Prosjektnummer
- 911260
- Ansvarlig person
- Karsten Gravdal
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskerutdanning - dr.grad
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
Cancer Res 2009 Jun;69(11):4708-15.
PMID: 19487287
Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1.
Proc Natl Acad Sci U S A 2009 Jul;106(29):12115-20. Epub 2009 jul 6
PMID: 19581582
WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence.
Clin Cancer Res 2008 Mar;14(5):1397-406.
PMID: 18316561
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer.
Clin Cancer Res 2007 Dec;13(23):7003-11.
PMID: 18056176
Vascular proliferation by Nestin/Ki-67 is a novel predictor of the clinical progress of prostate cancer
Konferanse, BCCR, mai 2008
Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prost
Virchows Arch, 1-7 (2005)
Angiogenesis and Epithelial-Mesenchymal Transition in Prostate Cancer
- Disputert:
- september 2011
- Hovedveileder:
- Lars A. Akslen
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest